Meclizine HCl is a first-generation antihistamine sold over the counter under brand names like Dramamine Less Drowsy and Bonine, and it remains one of the most commonly used drugs for motion sickness and vertigo in the United States. It works primarily in the brain rather than in the inner ear itself, and while it is generally well tolerated in younger adults, its safety profile gets more complicated in older populations. Beyond its familiar uses, meclizine has recently attracted attention from researchers studying conditions that have nothing to do with dizziness, from a rare bone-growth disorder in children to neurodegeneration.
How Meclizine Works in the Brain
Meclizine belongs to the piperazine class of antihistamines, and its anti-nausea and anti-vertigo effects come from blocking histamine H1 receptors along with weaker blockade of acetylcholine receptors. What’s interesting is where it acts. Rather than dampening the sensors in your inner ear directly, meclizine appears to work centrally, in the brainstem. Research using vestibular testing in humans found that meclizine affected the vestibulo-ocular reflex (the automatic eye movement your brain generates to stabilize vision during head turns) without changing the raw signals coming from the semicircular canals or the otolith organs of the inner ear. That points to a site of action in the medial vestibular nucleus, a relay hub in the brainstem where balance signals are processed and integrated.1Audiology and Neurotology. Pharmaceutical Countermeasures Have Opposite Effects on the Utricles and Semicircular Canals in Man
In practical terms, this means meclizine doesn’t stop your inner ear from detecting motion. It reduces your brain’s reaction to those signals, dialing down the mismatch between what your eyes see and what your balance organs sense. That mismatch is what drives motion sickness and many forms of vertigo. Because meclizine crosses the blood-brain barrier easily, it reaches the brainstem within an hour or so of swallowing a tablet, which is why the usual advice is to take it at least an hour before exposure to motion.
Effectiveness for Motion Sickness
Meclizine has been used for motion sickness since the 1950s, and modern controlled studies confirm it works, though with a caveat about intensity. A study that re-examined meclizine’s anti-motion-sickness effects under controlled laboratory conditions found that it prevented symptoms effectively at lower stimulation levels, the kind of motion you’d encounter on a ferry, a car ride, or a commercial flight. At more extreme provocations (think military aircraft, rough seas, or aggressive virtual-reality simulations), the protective effect diminished.2PubMed Central. The effects of meclizine on motion sickness revisited A review of the drug’s overall profile characterized it as effective for prevention and treatment of motion sickness during mild civilian travel, noting that its oral tablet form makes it convenient to take before a trip.3Clinical Medicine Insights: Therapeutics. Meclizine: Safety and Efficacy in the Treatment and Prevention of Motion Sickness
So if you’re taking a cruise or riding in the back seat of a car, meclizine is a solid preventive choice. If you’re headed into severe turbulence or rough open-ocean conditions, you may need something stronger, like scopolamine patches, which act through a different receptor pathway. The distinction matters because many people assume that if meclizine doesn’t help in extreme conditions, it must not work at all. It does work; it just has a ceiling.
Meclizine for Vertigo
Emergency departments frequently hand out meclizine for acute vertigo episodes, and the evidence suggests it offers real relief. In a randomized, double-blind trial comparing meclizine 25 mg to diazepam 5 mg in adults with acute peripheral vertigo, both drugs improved symptoms significantly, and the improvements were statistically indistinguishable. After 60 minutes, the meclizine group reported an average improvement of 40 points on a 100-point dizziness scale, while the diazepam group improved by 36 points.4PubMed. Diazepam and Meclizine Are Equally Effective in the Treatment of Vertigo: An Emergency Department Randomized Double-Blind Placebo-Controlled Trial That’s a meaningful finding because diazepam is a benzodiazepine with addiction potential and heavier sedation, while meclizine is available without a prescription and carries far less risk of dependence.
A meta-analysis pooling data from 13 studies of histamine-blocking drugs for peripheral vertigo found that these medications, meclizine among them, were associated with substantially better outcomes compared to placebo or no treatment.5The Journal of International Advanced Otology. Histamine Antagonists for Treatment of Peripheral Vertigo: A Meta-Analysis That said, vertigo specialists often point out that meclizine should be a short-term solution. For conditions like benign paroxysmal positional vertigo (BPPV), the gold-standard treatment is a repositioning maneuver performed by a clinician, not ongoing medication. Meclizine can blunt the spinning sensation in the acute phase, but it won’t fix the underlying cause of BPPV. Using it continuously can actually slow your brain’s natural process of recalibrating to the vestibular problem, a process called vestibular compensation.
Side Effects and Cognitive Impact
Drowsiness is the side effect people most associate with meclizine, and it’s real, though typically milder than what you’d get from older antihistamines like diphenhydramine (the active ingredient in original Dramamine and Benadryl). Dry mouth, blurred vision, and constipation also occur because of meclizine’s anticholinergic activity, the same acetylcholine-blocking property that contributes to its anti-nausea effect.
One reassuring finding comes from cognitive testing. In a study designed to measure the mental side effects of various anti-motion-sickness drugs, meclizine 25 mg had no measurable effect on visual working memory, whether participants were sitting still or being spun in a rotary chair. By contrast, scopolamine and lorazepam both impaired performance on the same memory task.6Neurotoxicology and Teratology. Effects of drug countermeasures for space motion sickness on working memory in humans For someone choosing between motion sickness drugs before, say, a work trip where mental sharpness matters, that’s useful information. Meclizine may make you a bit sleepy, but it’s unlikely to leave you foggy in the way that scopolamine or a benzodiazepine can.
Why Older Adults Should Be Cautious
The safety picture changes significantly for people over 65. Meclizine is a first-generation antihistamine, and that class of drugs crosses the blood-brain barrier readily and produces anticholinergic effects that compound with age. The American Geriatrics Society’s Beers Criteria, a widely referenced list of medications considered potentially inappropriate for older adults, flags first-generation antihistamines. The Choosing Wisely campaign has similarly recommended against using highly anticholinergic medications in older adults without first considering safer alternatives or non-drug approaches.7JAMA Otolaryngology–Head & Neck Surgery. Meclizine Use and Subsequent Falls Among Patients With Dizziness
The concern isn’t just drowsiness. Anticholinergic burden in older adults is associated with falls and fractures, and a recent study specifically examined the link between meclizine use and subsequent falls among patients with dizziness.8JAMA Otolaryngology–Head & Neck Surgery. Meclizine Use and Subsequent Falls Among Patients With Dizziness The irony is hard to miss: a drug prescribed because someone is dizzy may increase their risk of falling. For older adults dealing with recurrent vertigo, vestibular rehabilitation therapy (a structured exercise program that retrains the brain’s balance responses) is often more appropriate than ongoing medication. When meclizine is used, it should ideally be limited to the shortest course possible during acute episodes.
Meclizine in Pregnancy
Meclizine has a long track record of use during pregnancy for nausea and vomiting, particularly in Scandinavian countries where it has been extensively studied. A large Swedish study examining delivery outcomes after meclizine use in early pregnancy found no increased risk of congenital malformations. In fact, the rate of malformations was slightly lower than expected among women who took meclizine, though researchers attributed that to indirect effects of the nausea and vomiting itself rather than a protective property of the drug. The study concluded that meclizine can be used without apparent risk for nausea and vomiting in pregnancy.9PubMed. Delivery outcome after the use of meclozine in early pregnancy
This is worth knowing because pregnant women often hear conflicting messages about which anti-nausea drugs are safe. Meclizine is classified by the FDA in the older pregnancy category B, meaning animal studies showed no harm and there are adequate human data supporting safety, though specific guidance should always come from an obstetrician. It tends to be less sedating than some alternatives, which matters during a time when fatigue is already a constant companion.
Why the Same Dose Hits People Differently
If you’ve ever noticed that meclizine makes one family member drowsy for hours while barely affecting another, genetics offers a likely explanation. Meclizine is primarily broken down by the liver enzyme CYP2D6, and that enzyme is subject to well-known genetic variation across the population. Some people are ultrarapid metabolizers who clear the drug quickly, while others are poor metabolizers who process it much more slowly and therefore experience stronger and longer-lasting effects from the same dose.10PubMed. Meclizine metabolism and pharmacokinetics: formulation on its absorption
This genetic variability also helps explain the wide range of side-effect experiences people report. Two people taking the same 25 mg tablet can have very different blood levels of active drug at the two-hour mark. For most people, this doesn’t require any special action beyond paying attention to how the drug affects you personally before assuming it’s safe to drive or operate equipment. But if you happen to know your CYP2D6 status from pharmacogenomic testing done for another medication, that information is relevant to how you’d respond to meclizine as well.
Newer Formulations
The standard meclizine tablet has been around for decades, but there’s ongoing work to improve its delivery. Researchers have developed chewable tablet formulations that combine meclizine with pyridoxine (vitamin B6) and are designed for faster absorption. The goal is quicker onset of action, which matters when you need relief from motion sickness that’s already started rather than having the luxury of dosing an hour ahead of time. These chewable forms are also intended to be more palatable and usable across a wider range of ages.11PubMed Central. Formulation of New Chewable Oral Dosage Forms of Meclizine and Pyridoxine Hydrochloride
The addition of pyridoxine is not random. Vitamin B6 has its own mild anti-nausea properties, and the combination is sometimes used specifically for pregnancy-related nausea (the prescription product Diclegis contains a related antihistamine plus pyridoxine). Whether these newer chewable meclizine-pyridoxine tablets will replace the familiar swallowed tablets remains to be seen, but the push toward faster-acting and more flexible dosage forms reflects how entrenched meclizine is in anti-nausea treatment.
Unexpected Research Beyond Dizziness
Some of the most surprising recent work on meclizine has nothing to do with motion sickness. Because it crosses into the brain easily and is already approved for human use, researchers have been investigating whether it could be repurposed for entirely different conditions.
In models of Huntington’s disease, a devastating neurodegenerative disorder caused by abnormal polyglutamine protein repeats, meclizine suppressed cell death across mouse, roundworm, and fruit fly models of the disease. The protective effect wasn’t due to meclizine’s antihistamine or anticholinergic properties but rather to a separate ability to dampen mitochondrial respiration, essentially slowing down the energy-producing machinery of cells in a way that reduces the toxic oxidative stress driving neuronal death.12PubMed Central. Meclizine is neuroprotective in models of Huntington’s disease This is still preclinical work, not a treatment you’d use today, but the idea that a cheap, familiar over-the-counter drug might have neuroprotective potential has understandably generated interest.
In a separate line of research, meclizine was found to act as an inhibitor of mTORC1, a major cellular growth-signaling pathway. That property led to a longevity study in genetically diverse mice. Males given meclizine starting at 12 months of age (roughly middle-aged in mouse terms) lived about 8% longer at the median compared to untreated controls.13PubMed. Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used Lifespan extension in mice doesn’t translate directly to humans, and the effect was only seen in males, but the finding adds meclizine to the small list of existing drugs being seriously explored for anti-aging potential alongside better-known candidates like rapamycin and metformin.
A Potential Treatment for Achondroplasia
Perhaps the most tangible repurposing effort involves achondroplasia, the most common form of dwarfism in humans. Achondroplasia is caused by an overactive fibroblast growth factor receptor 3 (FGFR3), which essentially puts the brakes on bone growth too aggressively. Researchers discovered through a drug-repositioning screen that meclizine inhibits FGFR3 signaling, and in a transgenic mouse model of achondroplasia, clinical-range doses of meclizine rescued the short-stature phenotype by promoting longitudinal bone growth, increasing bone volume, and improving the quality of the spongy bone tissue in the growth plates.14PubMed Central. Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia
These animal results were promising enough that a Phase 1b clinical trial was conducted in children with achondroplasia. The trial used doses of 1 and 2 mg/kg/day and focused primarily on safety and pharmacokinetics rather than measuring growth outcomes, which would require a longer study. The researchers confirmed that the drug-repositioning strategy had correctly identified meclizine’s ability to inhibit FGFR3.15PLoS ONE. Phase 1b study on the repurposing of meclizine hydrochloride for children with achondroplasia Whether meclizine could eventually become a practical oral treatment for achondroplasia is still an open question, particularly now that a purpose-built drug, vosoritide, has been approved for the condition. But meclizine’s enormous cost advantage as a generic over-the-counter medication makes it an appealing option for further study, especially in healthcare systems with limited resources.
Common Mistakes People Make With Meclizine
A few patterns come up repeatedly when people use meclizine without much guidance. The first is timing. Meclizine works best when taken before motion exposure, not after you’re already green in the face. Waiting until symptoms are full-blown means the drug has to fight an already-activated nausea pathway, which it does less effectively than preventing that pathway from ramping up in the first place.
The second mistake is long-term use for chronic dizziness. If you’ve been taking meclizine daily for weeks or months because you feel unsteady, you’re likely masking a problem that needs proper diagnosis. Chronic dizziness can stem from dozens of causes, from vestibular migraines to cardiovascular issues to anxiety disorders. Meclizine suppresses symptoms without addressing any of them, and its anticholinergic effects can interfere with vestibular compensation, the brain’s ability to adapt to inner-ear damage. In other words, the drug can slow your recovery from the very condition that’s making you dizzy.
The third is combining meclizine with other sedating or anticholinergic drugs without realizing the effects stack. If you’re already taking a sleep aid containing diphenhydramine, or if you’re on an older tricyclic antidepressant, adding meclizine piles on more anticholinergic load. The result can be pronounced dry mouth, urinary retention, confusion (especially in older adults), and excessive sedation. Checking the full ingredient list of any over-the-counter sleep or allergy product you use is worth the thirty seconds it takes before adding meclizine to the mix.